IGF binding protein-3 treatment alters intestinal cell proliferation but not body weight of adult cystic fibrosis transmembrane conductance regulator deficient mice

Pediatric Research

Volumn 69, Issue 2, 2011, Pages 129-134

  Canale Zambrano, Juan Carlos ^a   Haston, Christina K ^a,b  

^a Department of Human Genetics ^*  (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; INTESTINE CELL; INTESTINE CRYPT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

AGE FACTORS; ANIMALS; APOPTOSIS; BODY WEIGHT; CELL PROLIFERATION; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; INJECTIONS, INTRAPERITONEAL; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INTESTINES; MICE; MICE, INBRED CFTR; RECOMBINANT PROTEINS; RNA, MESSENGER; SERUM ALBUMIN; TRIGLYCERIDES;

EID: 79951642810     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318205128d     Document Type: Article

References (37)

1. O'Sullivan BP, Freedman SD 2009 Cystic fibrosis. Lancet 373:1891-1904
2. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH 1992 An animal-model for cystic-fibrosis made by gene targeting. Science 257:1083-1088
3. Kent G, Oliver M, Foskett JK, Frndova H, Durie P, Forstner J, Forstner GG, Riordan JR, Percy D, Buchwald M 1996 Phenotypic abnormalities in long-term surviving cystic fibrosis mice. Pediatr Res 40:233-241 (Pubitemid 26249675)
4. Canale-Zambrano JC, Poffenberger MC, Cory SM, Humes DG, Haston CK 2007 Intestinal phenotype of variable-weight cystic fibrosis knockout mice. Am J Physiol Gastrointest Liver Physiol 293: G222-G229 (Pubitemid 47105164)
5. Steeb CB, Shoubridge CA, Tivey DR, Read LC 1997 Systemic infusion of IGF-I or LR (3) IGF-I stimulates visceral organ growth and proliferation of gut tissues in suckling rats. Am J Physiol 272: G522-G533
6. Williams KL, Fuller CR, Fagin J, Lund PK 2002 Mesenchymal IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions. Am J Physiol Gastrointest Liver Physiol 283: G875-G885 (Pubitemid 35033930)
7. Donovan EA, Kummar S 2008 Role of insulin-like growth factor-1R system in colorectal carcinogenesis. Crit Rev Oncol Hematol 66:91-98 (Pubitemid 351446110)
8. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854 (Pubitemid 35454590)
9. Jogie-Brahim S, Feldman D, Oh Y 2009 Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr Rev 30:417-437
10. Winesett DE, Ulshen MH, Hoyt EC, Mohapatra NK, Fuller CR, Lund PK 1995 Regulation and localization of the insulin-like growth-factor system in small-bowel during altered nutrient status. Am J Physiol 268: G631-G640
11. Bushman TL, Kuemmerle JF 1998 IGFBP-3 and IGFBP-5 production by human intestinal muscle: reciprocal regulation by endogenous TGF-beta 1. Am J Physiol 275: G1282-G1290
12. Williams AC, Collard TJ, Perks CM, Newcomb P, Moorghen M, Holly JM, Paraskeva C 2000 Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res 60:22-27 (Pubitemid 30058723)
13. Alami N, Page V, Yu QN, Jerome L, Paterson J, Shiry L, Leyland-Jones B 2008 Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models. Growth Horm IGF Res 18:487-496
14. Haston CK, Cory S, Lafontaine L, Dorion G, Hallett MT 2006 Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model. Physiol Genomics 25:336-345
15. O'Brien TJ, Létuvé S, Haston CK 2005 Radiation-induced strain differences in mouse alveolar inflammatory cell apoptosis. Can J Physiol Pharmacol 83:117-122 (Pubitemid 40754783)
16. Rajah R, Valentinis B, Cohen P 1997 Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factorbeta 1 on programmed cell death through a p53-and IGF-independent mechanism. J Biol Chem 272:12181-12188 (Pubitemid 27202802)
17. Taylor AM, Bush A, Thomson A, Oades PJ, Marchant JL, Bruce Morgan C, Holly J, Ahmed L, Dunger DB 1997 Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis. Arch Dis Child 76:304-309 (Pubitemid 27174538)
18. Rosenberg LA, Schluchter MD, Parlow AF, Drumm ML 2006 Mouse as a model of growth retardation in cystic fibrosis. Pediatr Res 59:191-195 (Pubitemid 43840987)
19. Street ME, Ziveri MA, Spaggiari C, Viani I, Volta C, Grzincich GL, Virdis R, Bernasconi S 2006 Inflammation is a modulator of the insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis. Eur J Endocrinol 154:47-52 (Pubitemid 43250735)
20. Bijvelds MJ, Bronsveld I, Havinga R, Sinaasappel M, de Jonge HR, Verkade HJ 2005 Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events. Am J Physiol Gastrointest Liver Physiol 288: G646-G653 (Pubitemid 40388175)
21. Booth CC, Evans KT, Menzies T, Street DF 1959 Intestinal hypertrophy following partial resection of the small bowel in the rat. Br J Surg 46:403-410
22. Albiston AL, Taylor RG, Herington AC, Beveridge DJ, Fuller PJ 1992 Divergent ileal IGF-I and IGFBP-3 gene expression after small bowel resection: a novel mechanism to amplify IGF action? Mol Cell Endocrinol 83: R17-R20
23. Gillingham MB, Kritsch KR, Murall SG, Lund PK, Ney DM 2001 Resection upregulates the IGF-I system of parenterally fed rats with jejunocolic anastomosis. Am J Physiol Gastrointest Liver Physiol 281: G1158-G1168
24. Edmondson SR, Thumiger SP, Kaur P, Loh B, Koelmeyer R, Li A, Silha JV, Murphy LJ, Wraight CJ, Werther GA 2005 Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo. Br J Dermatol 152:225-230 (Pubitemid 40343591)
25. Cianfarani S, Geremia C, Puglianiello A, Maiorana A, Germani D 2007 Late effects of disturbed IGF signaling in congenital diseases. Endocr Dev 11:16-27
26. Vrieling A, Voskuil DW, Bosma A, Majoor DM, van Doorn J, Cats A, Depla AC, Timmer R, Witteman BJ, Wesseling J, Kampman E, Van't Veer LJ 2009 Expression of insulin-like growth factor system components in colorectal tissue and its relation with serum IGF levels. Growth Horm IGF Res 19:126-135
27. Garrison AP, Dekaney CM, von Allmen DC, Lund PK, Henning SJ, Helmrath MA 2009 Early but not late administration of glucagon-like peptide-2 following ileocecal resection augments putative intestinal stem cell expansion. Am J Physiol Gastrointest Liver Physiol 296: G643-G650
28. Murali SG, Liu X, Nelson DW, Hull AK, Grahn M, Clayton MK, Pintar JE, Ney DM 2007 Intestinotrophic effects of exogenous IGF-I are not diminished in IGF binding protein-5 knockout mice. Am J Physiol Regul Integr Comp Physiol 292: R2144-R2150 (Pubitemid 47080672)
29. Cheung QC, Yuan Z, Dyce PW, Wu D, DeLange K, Li J 2009 Generation of epidermal growth factor-expressing Lactococcus lactis and its enhancement on intestinal development and growth of early-weaned mice. Am J Clin Nutr 89:871-879
30. Norkina O, Burnett TG, De Lisle RC 2004 Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun 72:6040-6049 (Pubitemid 39303719)
31. Canale-Zambrano JC, Auger ML, Haston CK 2010 Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice. Am J Physiol Gastrointest Liver Physiol 299: G381-G390
32. de Lisle RC, Sewell R, Meldi L 2010 Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine. Neurogastroenterol Motil 22:341-e87
33. Holzenberger M, Hamard G, Zaoui R, Leneuve P, Ducos B, Beccavin C, Périn L, Le Bouc Y 2001 Experimental IGF-I receptor deficiency generates a sexually dimorphic pattern of organ-specific growth deficits in mice, affecting fat tissue in particular. Endocrinology 142:4469-4478 (Pubitemid 32907078)
34. Colangelo LA, Liu K, Gapstur SM 2004 Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and cardiovascular disease risk factors in young black men and white men: the CARDIA Male Hormone Study. Am J Epidemiol 160:750-757 (Pubitemid 39362212)
35. Sídlová K, Pechová M, Kotaska K, Průsa R 2002 Insulin-like growth factor binding protein-3 in patients with liver cirrhosis. Physiol Res 51:587-590 (Pubitemid 36168666)
36. Guilherme A, Virbasius JV, Puri V, Czech MP 2008 Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367-377 (Pubitemid 351574198)
37. Bannerjee K, Camacho-Hübner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, Sanderson IR, Croft NM 2004 Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 38:270-275